Pnc Financial Services Group, Inc. Protagonist Therapeutics, Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,992 shares of PTGX stock, worth $109,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,992
Previous 1,441
38.24%
Holding current value
$109,101
Previous $55,000
74.55%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$334 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$315 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$313 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$234 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$164 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.69B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...